PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TEVA vs. AZN.L
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


TEVAAZN.L
YTD Return76.34%15.84%
1Y Return74.34%12.24%
3Y Return (Ann)26.78%16.40%
5Y Return (Ann)18.36%14.49%
10Y Return (Ann)-9.12%13.89%
Sharpe Ratio2.240.68
Daily Std Dev34.87%21.38%
Max Drawdown-93.11%-49.99%
Current Drawdown-72.52%-9.49%

Fundamentals


TEVAAZN.L
Market Cap$20.86B£184.92B
EPS-$0.39£3.16
PEG Ratio1.290.88
Total Revenue (TTM)$16.30B£49.13B
Gross Profit (TTM)$8.07B£40.33B
EBITDA (TTM)$4.50B£14.82B

Correlation

-0.50.00.51.00.2

The correlation between TEVA and AZN.L is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

TEVA vs. AZN.L - Performance Comparison

In the year-to-date period, TEVA achieves a 76.34% return, which is significantly higher than AZN.L's 15.84% return. Over the past 10 years, TEVA has underperformed AZN.L with an annualized return of -9.12%, while AZN.L has yielded a comparatively higher 13.89% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%AprilMayJuneJulyAugustSeptember
38.21%
21.92%
TEVA
AZN.L

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TEVA vs. AZN.L - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and AstraZeneca plc (AZN.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TEVA
Sharpe ratio
The chart of Sharpe ratio for TEVA, currently valued at 2.27, compared to the broader market-4.00-2.000.002.002.27
Sortino ratio
The chart of Sortino ratio for TEVA, currently valued at 3.26, compared to the broader market-6.00-4.00-2.000.002.004.003.26
Omega ratio
The chart of Omega ratio for TEVA, currently valued at 1.39, compared to the broader market0.501.001.502.001.39
Calmar ratio
The chart of Calmar ratio for TEVA, currently valued at 0.89, compared to the broader market0.001.002.003.004.005.000.89
Martin ratio
The chart of Martin ratio for TEVA, currently valued at 12.08, compared to the broader market-10.00-5.000.005.0010.0015.0020.0012.08
AZN.L
Sharpe ratio
The chart of Sharpe ratio for AZN.L, currently valued at 0.92, compared to the broader market-4.00-2.000.002.000.92
Sortino ratio
The chart of Sortino ratio for AZN.L, currently valued at 1.32, compared to the broader market-6.00-4.00-2.000.002.004.001.32
Omega ratio
The chart of Omega ratio for AZN.L, currently valued at 1.18, compared to the broader market0.501.001.502.001.18
Calmar ratio
The chart of Calmar ratio for AZN.L, currently valued at 0.96, compared to the broader market0.001.002.003.004.005.000.96
Martin ratio
The chart of Martin ratio for AZN.L, currently valued at 4.28, compared to the broader market-10.00-5.000.005.0010.0015.0020.004.28

TEVA vs. AZN.L - Sharpe Ratio Comparison

The current TEVA Sharpe Ratio is 2.24, which is higher than the AZN.L Sharpe Ratio of 0.68. The chart below compares the 12-month rolling Sharpe Ratio of TEVA and AZN.L.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AprilMayJuneJulyAugustSeptember
2.27
0.92
TEVA
AZN.L

Dividends

TEVA vs. AZN.L - Dividend Comparison

TEVA has not paid dividends to shareholders, while AZN.L's dividend yield for the trailing twelve months is around 1.94%.


TTM20232022202120202019201820172016201520142013
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.49%3.75%2.08%2.37%3.19%
AZN.L
AstraZeneca plc
1.94%2.21%1.98%2.33%2.95%2.87%3.44%4.28%4.50%3.95%3.73%5.03%

Drawdowns

TEVA vs. AZN.L - Drawdown Comparison

The maximum TEVA drawdown since its inception was -93.11%, which is greater than AZN.L's maximum drawdown of -49.99%. Use the drawdown chart below to compare losses from any high point for TEVA and AZN.L. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-72.52%
-9.18%
TEVA
AZN.L

Volatility

TEVA vs. AZN.L - Volatility Comparison

Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 6.76% compared to AstraZeneca plc (AZN.L) at 6.04%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than AZN.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%AprilMayJuneJulyAugustSeptember
6.76%
6.04%
TEVA
AZN.L

Financials

TEVA vs. AZN.L - Financials Comparison

This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and AstraZeneca plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Please note, different currencies. TEVA values in USD, AZN.L values in GBp